Order Article Reprints

Benda M, Reimann P, Bletzacher E, Muendlein A, Bernhard B, Hartmann B, Huynh M, Gasser K, Zojer N, Lang T, et al. Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q. Cancers. 2025; 17(8):1261. https://doi.org/10.3390/cancers17081261

Benda, Magdalena, Patrick Reimann, Elena Bletzacher, Axel Muendlein, Benda Bernhard, Bernd Hartmann, Minh Huynh, Klaus Gasser, Niklas Zojer, Theresia Lang, and et al. 2025. "Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q" Cancers 17, no. 8: 1261. https://doi.org/10.3390/cancers17081261

Benda, M., Reimann, P., Bletzacher, E., Muendlein, A., Bernhard, B., Hartmann, B., Huynh, M., Gasser, K., Zojer, N., Lang, T., Göbel, G., Bohn, J.-P., Schmidt, S., Gunsilius, E., Nachbaur, D., Jukic, E., Locher, M., Willenbacher, E., Willenbacher, W., ... Steiner, N. (2025). Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q. Cancers, 17(8), 1261. https://doi.org/10.3390/cancers17081261